HiFiBiO Company
HiFiBiO provides proprietary single cell technologies for applications in drug and biomarker discovery and development.
Investors
.png)
Funding Status:
Late Stage Venture
Industry:
Early Drug Development
Estimated Revenue:
$1M to $10M
Headquarters:
Paris, Ile-de-France, France
Total Funding:
179500000.0
Last Funding Date:
2021-06-14
Last Funding Type:
Series D
Employee Number:
101-250
Investors Number:
21.0
Founded Date:
2013-01-01